CDH6/Cadherin-6 hFc Chimera, Human
CDH6/Cadherin-6 HFc Chimera, Human

CDH6/Cadherin-6 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 90%.

CDH6/Cadherin-6 hFc Chimera, Human

Cadherin 6 (CDH6) is an adhesion molecule localizing to the endometrial luminal epithelial cell surface in the mid-secretory/receptive phase and knockdown of CDH6 in the Ishikawa cells (receptive endometrial epithelial cell line) compromises cell integrity.
Z05158
¥55,963.00

Ask us a question
Product Introduction
Species Human
Protein Construction
CDH6/Cadherin 6 (Thr19-Ala615)
Accession # P55285-1		 hFc
N-term C-term
Purity > 85% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 93.15 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 100-130 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • CDH6/Cadherin-6 HFc Chimera, Human
    • CDH6/Cadherin-6 HFc Chimera, Human

    CDH6/Cadherin-6 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 90%.


Background
Target Background Cadherin 6 (CDH6) is an adhesion molecule localizing to the endometrial luminal epithelial cell surface in the mid-secretory/receptive phase and knockdown of CDH6 in the Ishikawa cells (receptive endometrial epithelial cell line) compromises cell integrity.
Synonyms Cadherin-6; Cadherin6; K-cadherin; CDH6; CAD6; KCAD;

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.